Abstract: A compound having the formula (I), a physiologically tolerable salt of the compound having the formula (I) and/or a steroisomeric form of the compound having the formula (I), in which one residue R.sup.1 or R.sup.2 stands for the formula (II), are suitable for preparing medicaments for the therapy of inflammations, asthma, rheumatoid diseases and auto-immune diseases.
Type:
Grant
Filed:
November 19, 1996
Date of Patent:
September 29, 1998
Assignee:
Hoechst Aktienegesellschaft
Inventors:
Wilfried Schwab, Hiristo Anagnostopulos, Robert Ryder Bartlett, Rudolf Schleyerbach, Klaus Ulrich Weithmann